Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Other 1

Conditions

Breast Neoplasms 3Obesity 1Neoplasms 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × BaseLine dental cement × 1 year × Clear all
NCT07447440 2026-03-11

RESOLBE

Clinica Universidad de Navarra, Universidad de Navarra

Recruiting
60 enrolled
BreastOther

Breast Neoplasms, Neoplasms, Obesity

NCT06640881 2025-10-01

REPEAT

Amsterdam UMC, location VUmc

Phase 2 Recruiting
25 enrolled
Breast

Breast Neoplasms

NCT05386719 2025-06-24

Cardiometabolic Screening Program

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
450 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡